The ADVANCED RESEARCH INSTITUTE (ARI) On staff at ARI we have three Urology surgeons, an Internal medicine, three G.I. Investigators, an OB/GYN, a podiatrist, an endocrinologist, a Director of Research and a team of Registered Nurses. We are dedicated to conducting clinical trials, affording our patients' privacy and comfort with a commitment to high standards of practice and quality assurance.

Our physicians have collectively over 25 years of Clinical Research experience in the following areas:

• Erectile Dysfunction
• Urinary Tract Agents and Antiinfective Agents
• Benign Prostatic Hyperplasia
• Oncology
  Prostate Cancer
  Bladder Cancer
• Urinary Incontinence
• Urinary System - Infections
• Biologicals - Vaccines
• Urodynamics
• Biofeedback
• PK Studies
• Pain Management
• Device Trials
• Nationwide Outcome Resource Study
• UHC Developed Protocols
• Urinary System - Calculi
• Brachytheraphy
• Hypogonadism
• Hypertension
• Diabetes Mellitus
• Dyspepsia/IBS

Our Sponsors have included:

Ilex TAP Holdings, Inc. Abbott Laboratories Pharmacia & Upjohn Glaxo Wellcome Ortho McNeil Pharmaceuticals Anthra Pharmaceuticals Atrix Laboratories

Johnson & Johnson Theragenics National Cancer Institute Trials Sanifi-Synthelab Bristol Myers Squibb Zeneca Pharmaceuticals Schering Plough

Our setting allows for a variety of surgical, drug, and device trials to include Phase I through Phase IV studies. In addition to the out-patient ambulatory surgery center, we have on site:

• CLIA Certified Laboratory
• Full X-ray capabilities
• Transrectal Ultrasound
• Diagnostic Bladder Ultrasound
• Penile Dopplers
• Rigiscans
• Urodynamics
• Biofeedback
• Bone Density Machine
• Dry Ice Availability
• 12-Lead Cardioline Delta 30D
• Urodyn 1000 Uroflow
• Brachytherapy
• Patient Education Seminars
• Nuaire Biological Safety Cabinet
• Revco -70° Freezer
• 12 Lead Atria 3000 ECG
• Haier locked refrigerator
• Detecto Scale- capacity 350 lbs. With Stadiometer
• Large and X-Large Bergen Brunswig Blood Pressure Cuffs
• ACMI ALU-2B Cystoscopy Machine with ACMI micro digital IP 4.2 View
• AARON 950 Electrosurgical Generator
• SVA DUET Logic cystometry equipment

Also available off site:

• Luna DPX Dexamwith 5.93 software for Body Composition
• Toshiba Echocardiogram Services
• Toshiba high Field MRI
• Hitachi Airis II open MRI

We are located across the street from a full service community hospital.

We are located one half hour from the Tampa International Airport. Brochures and maps are available.

Our site uses a central IRB for sponsor convenience and expediency.

Jerrold Sharkey, MD - Urologist
Raymond Behar, MD - Urologist
Juan Otheguy, MD - Urologist
Hugo Perez, MD - OB/GYN
Angel Rosario, MD, GI
Israel Crespo, MD, GI
Jesus Penabad, MD - Diabetes, Endocrinologist
Ira Bennett, DPM- Podiatrist
Malleswari Vangara, MD - Internal Medicine
Carey Rowan, MD - Ophthamologist

During our 25 years of Clinical Research experience, we have developed our own protocol for Prostate Cancer treatment utilizing Palladium Seed implantation, have conducted multiple trials for erectile dysfunction and male impotence, have participated in BPH device trials and numerous incontinence studies. We have participated in various cancer trials to include phase I trials for prostate cancer.

Susan Randall, RN
Director of Research

A published author with over 25 years of nursing experience, including University Phase I and private practice clinical trial experience.

The staff includes 3 full time clinical coordinators having a combined expertise and certification in the following areas:

• Urology
• Oncology
• Internal Medicine
• Endocrinology
• Gastroenterology
• IV Therapy
• Respiratory/Pulmonary
• Critical Care
• Wound, Ostomy, Continence (enterostomal therapy)
• Gynecology
• Podiatry

Our patient population ranges from age 18-95, 65% male; we currently have combined databases of 158,600 active patients.

CenterWatch is listing the following trials that are actively recruiting patients at this center.

• A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
• A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
• A Phase 3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
• A Phase 3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis

For more information, please contact:

Susan Randall
RN, Director of Research
Advanced Research Institute
BREAKING NEW GROUND IN MEDICINE
3633 Little Road, Suite 103
New Port Richey, FL 34655 USA
Phone: 727-835-3261
Fax: 727-845-0589
E-mail:

If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the E-mail form below. A representative from the research center will then follow up with you.

Name:
Address:
City:
State:
Zip:
Phone:
Email address:
Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

Last updated on June 20, 2008